Clinical trials
Active, not recruiting Carcinoma, Hepatocellular trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| AbbVie | 3 |
| Exelixis | 2 |
| Boston Scientific Corporation | 1 |
| Bristol-Myers Squibb | 1 |
| CStone Pharmaceuticals | 1 |
| Cardiovascular and Interventional Radiological Society of Europe | 1 |
| Eisai Inc. | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 20 |
| Liver Neoplasms | 6 |
| Neoplasms | 6 |
| Colorectal Neoplasms | 3 |
| Carcinoma | 2 |
| Endometrial Neoplasms | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Biliary Tract Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.